| |
| |
|
| Insider
Information: |
Vaishnaw Akshay |
| Relationship: |
President |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
22,774 |
|
|
Indirect Shares
|
515 |
|
|
| Direct
Value |
$3,400,158 |
|
|
|
Indirect Value
|
$76,890 |
|
|
| Total
Shares |
23,289 |
|
|
| Total
Value |
$3,477,048 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
2
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
2
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-2.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -26.9%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Alnylam Pharmaceuticals Inc |
ALNY |
President |
2023-08-04 |
22,774 |
2023-08-04 |
515 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
96 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ALNY |
Alnylam Pharmaceuticals I... |
EVP, Chief Medical Officer |
• – – |
2014-02-21 |
4 |
D |
$90.10 |
$235,611 |
I/I |
(2,615) |
0 |
0 |
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
President, R&D |
• – – |
2021-04-21 |
4 |
AS |
$135.41 |
$374,135 |
D/D |
(2,732) |
14,119 |
0 |
% |
|
| ALNY |
Alnylam Pharmaceuticals I... |
EVP, Chief Medical Officer |
• – – |
2012-11-30 |
4 |
AS |
$17.03 |
$48,072 |
D/D |
(2,823) |
12,588 |
0 |
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
EVP, Chief Medical Officer |
• – – |
2012-11-30 |
4 |
OE |
$7.10 |
$20,043 |
D/D |
2,823 |
15,411 |
0 |
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
President, R&D |
• – – |
2021-12-23 |
4 |
AS |
$186.22 |
$549,698 |
D/D |
(2,879) |
11,215 |
0 |
% |
|
| ALNY |
Alnylam Pharmaceuticals I... |
President, R&D |
• – – |
2021-04-19 |
4 |
AS |
$136.76 |
$510,192 |
D/D |
(3,706) |
19,202 |
0 |
% |
|
| ALNY |
Alnylam Pharmaceuticals I... |
President |
• – – |
2023-08-04 |
4 |
S |
$184.70 |
$753,986 |
D/D |
(4,057) |
22,774 |
0 |
% |
|
| ALNY |
Alnylam Pharmaceuticals I... |
EVP, Chief Medical Officer |
• – – |
2014-01-23 |
4 |
D |
$89.49 |
$420,424 |
D/D |
(4,698) |
7,890 |
0 |
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
EVP, Chief Medical Officer |
• – – |
2012-12-10 |
4 |
AS |
$17.00 |
$81,209 |
D/D |
(4,777) |
12,588 |
0 |
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
EVP, Chief Medical Officer |
• – – |
2012-12-10 |
4 |
OE |
$7.10 |
$33,917 |
D/D |
4,777 |
17,365 |
0 |
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
EVP, Chief Medical Officer |
• – – |
2012-09-12 |
4 |
OE |
$9.30 |
$45,719 |
D/D |
4,916 |
17,504 |
0 |
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
EVP, Chief Medical Officer |
• – – |
2012-09-12 |
4 |
AS |
$19.00 |
$93,404 |
D/D |
(4,916) |
12,588 |
0 |
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
EVP, R&D |
• – – |
2016-12-30 |
4 |
D |
$37.44 |
$187,200 |
D/D |
(5,000) |
10,297 |
0 |
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
President |
• – – |
2022-12-05 |
4 |
OE |
$42.22 |
$299,938 |
D/D |
5,079 |
23,425 |
0 |
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
President, R&D |
• – – |
2021-04-19 |
4 |
A |
$0.00 |
$0 |
D/D |
5,083 |
22,908 |
0 |
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
President |
• – – |
2023-04-26 |
4 |
A |
$0.00 |
$0 |
D/D |
5,312 |
20,282 |
0 |
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
President, R&D |
• – – |
2021-02-11 |
4 |
A |
$0.00 |
$0 |
D/D |
5,416 |
19,535 |
0 |
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
President, R&D |
• – – |
2020-04-07 |
4 |
A |
$0.00 |
$0 |
D/D |
5,417 |
16,632 |
0 |
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
President, R&D |
• – – |
2021-12-21 |
4 |
A |
$0.00 |
$0 |
D/D |
5,417 |
16,632 |
0 |
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
EVP, R&D, CMO |
• – – |
2015-11-25 |
4 |
OE |
$16.43 |
$99,750 |
D/D |
5,750 |
5,750 |
0 |
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
President |
• – – |
2022-08-04 |
4 |
D |
$189.76 |
$1,160,335 |
D/D |
(6,052) |
18,346 |
0 |
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
EVP, Chief Medical Officer |
• – – |
2013-03-11 |
4 |
OE |
$9.30 |
$58,125 |
D/D |
6,250 |
18,838 |
0 |
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
EVP, Chief Medical Officer |
• – – |
2013-03-11 |
4 |
AS |
$24.55 |
$153,415 |
D/D |
(6,250) |
12,588 |
0 |
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
EVP, Chief Medical Officer |
• – – |
2013-09-10 |
4 |
AS |
$57.39 |
$359,238 |
D/D |
(6,250) |
12,588 |
0 |
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
EVP, Chief Medical Officer |
• – – |
2013-09-10 |
4 |
OE |
$9.30 |
$58,125 |
D/D |
6,250 |
18,838 |
0 |
- |
|
96 Records found
|
|
Page 2 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
